
Houston Bionics
Houston Bionics | HoustonBionics |.
Date | Investors | Amount | Round |
---|---|---|---|
investor | €0.0 | round | |
investor investor investor investor investor investor investor investor | €0.0 | round | |
N/A | Seed | ||
Total Funding | 000k |
Related Content
HoustonBionics specializes in neurorehabilitation technology, focusing on the development and deployment of exoskeletal robotics systems. The company's flagship product, ExoRehab X, is designed to assist individuals recovering from strokes or traumatic brain injuries (TBI) by providing advanced at-home training solutions. The platform is particularly beneficial for those who have transitioned from inpatient therapy and can be effective even 12 years post-injury.
HoustonBionics operates within the healthcare and medical technology market, targeting patients who require long-term rehabilitation. The business model revolves around direct sales of the ExoRehab X system, as well as offering complimentary video consultations to assess patient needs and device suitability. Revenue is generated through the sale of these specialized rehabilitation devices and potentially through follow-up services and support.
The company has garnered positive feedback from clinical use at the Texas Medical Center in Houston, TX, which has fueled its commitment to improving patient mobility and recovery outcomes.
Keywords: neurorehabilitation, exoskeletal robotics, stroke recovery, TBI therapy, at-home training, patient mobility, healthcare technology, medical devices, rehabilitation solutions, clinical feedback.